Search Results - Marschke, R.F.

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    414 Clinical pharmacokinetics and pharmacodynamics of CX-4945, a novel inhibitor of protein kinase CK2: Interim report from the phase 1 clinical trial

    414 Clinical pharmacokinetics and pharmacodynamics of CX-4945, a novel inhibitor of protein kinase CK2: Interim report from the phase 1 clinical trial by Padgett, C.S, Lim, J.K.C, Marschke, R.F, Northfelt, D.W, Andreopoulou, E, Hoff, D.D. Von, Anderes, K, Ryckman, D.M, Chen, T.K, O'Brien, S.E

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    358 POSTER A phase I and pharmacokinetic (PK) study of CX-3543, a protein-rDNA quadruplex inhibitor, in patients (pts) with advanced solid tumors

    358 POSTER A phase I and pharmacokinetic (PK) study of CX-3543, a protein-rDNA quadruplex inhibitor, in patients (pts) with advanced solid tumors by Ricart, A.D., Papadopoulos, K.P., Von Hoff, D.D., Lim, J.K.C., Marschke, R.F.

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: